CARINA JOE ILMUWAN INDONESIA PENEMU ASTRAZENECA WAKILI TIMNYA RAIH PENGHARGAAN PRIDE OF BRITAIN!

Summary

This video highlights the inspiring story of Karina Citra Dewi Jo, an Indonesian scientist who played a crucial role in the creation of the AstraZeneca COVID-19 vaccine. Her innovative contribution, involving a breakthrough formula that increased vaccine production by ten times, has had a significant global impact. Despite her achievements, Karina remains humble, emphasizing her commitment to learning and improving. The video also emphasizes the hard work and dedication of her team, alongside the efforts of partners worldwide, to make the vaccine affordable and accessible. Viewers are encouraged to stay updated, follow health protocols, and share the news.

Takeaways

• 😀 Karina Citra Dewi Jo, an Indonesian female scientist, played a pivotal role in developing the AstraZeneca COVID-19 vaccine.
• 😀 The AstraZeneca vaccine, which is widely used globally, was developed intensively by Oxford University.
• 😀 Karina's discovery of a specific formula in 2012 allowed for a significant increase in vaccine production.
• 😀 The AstraZeneca vaccine has been used in over 170 countries and produced in laboratories around the world.
• 😀 One of the advantages of the AstraZeneca vaccine is its cost-effectiveness, with lower production and distribution costs.
• 😀 Dr. Sandy, the head of AstraZeneca's manufacturing team, praised Karina's contribution to the vaccine's production process.
• 😀 Karina remains humble about her achievements, expressing a desire to learn more from her superiors and mentors.
• 😀 Despite the success, Karina feels she still has a lot to learn and doesn't feel proud yet of her work.
• 😀 Dr. Sandy was concerned about the health of his team, especially as they had to continue working amid the pandemic.
• 😀 Thanks to Karina's persistence and teamwork, the AstraZeneca vaccine was created and distributed worldwide, benefiting many people.

Q & A

Who is Karina Citra Dewi Jo?

Karina Citra Dewi Jo is an Indonesian female scientist who played a significant role in the development of the AstraZeneca COVID-19 vaccine.

What notable achievement did Karina Citra Dewi Jo contribute to?

Karina Citra Dewi Jo contributed to the creation of the AstraZeneca COVID-19 vaccine, which is one of the most widely used vaccines globally.

What is the AstraZeneca vaccine, and why is it significant?

The AstraZeneca COVID-19 vaccine is a widely used vaccine developed in collaboration with Oxford University. It is significant due to its large-scale distribution and affordability.

How did Karina Citra Dewi Jo impact the production of the vaccine?

Karina discovered a specific formula involving two tablespoons of cells, which significantly increased the production capacity of the AstraZeneca vaccine by ten times.

When did Karina make her discovery that improved vaccine production?

Karina made her groundbreaking discovery on January 15, 2012, which led to a tenfold increase in vaccine production.

What other countries are using the AstraZeneca vaccine?

The AstraZeneca vaccine is currently used in more than 170 countries, including Indonesia.

What is the advantage of the AstraZeneca vaccine's production?

The AstraZeneca vaccine's production is advantageous due to its low cost, which makes it more affordable and accessible for global distribution.

Who is Dr. Sandy Double, and what role did he play in the vaccine's success?

Dr. Sandy Double is the head of the AstraZeneca manufacturing team. He praised Karina's efforts in improving vaccine production and highlighted the teamwork that enabled global distribution.

How did Karina Citra Dewi Jo feel about her success?

Despite her success, Karina expressed that she still has a lot to learn and is not fully satisfied with her achievements. She emphasized that she does extra work but remains humble and continues to learn from her superiors.

What concerns did Dr. Sandy Double have during the vaccine research?

Dr. Sandy Double was concerned about the health of his team members during the research, particularly regarding the risk of exposure to the coronavirus while working on the vaccine development.